Michael E. Goldberg is David Mahoney Professor of Brain and Behavior in the departments of neuroscience, neurology, psychiatry and ophthalmology at Columbia University College of Physicians and Surgeons, director of the Mahoney-Keck Center for Brain and Behavior Research, and is an active clinical neurologist. His neuroscience research focuses on the physiological basis of cognitive processes such as visual attention, spatial perception and decision-making. He earned his M.D. from Harvard Medical School in 1968. From 1978 to 2001, Goldberg was a senior investigator at the Laboratory of Sensorimotor Research at the National Eye Institute in Bethesda, Maryland. He is a fellow of the American Academy of Arts and Sciences and the American Association for the Advancement of Science, and an elected member of the National Academy of Sciences. He is a past president of the Society for Neuroscience, and now chair of the society’s Committee on Animals in Research.
Michael E. Goldberg
David Mahoney Professor of Brain and Behavior
Columbia University
Explore more from The Transmitter
Infant Brain Imaging Study findings, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 23 March.
Infant Brain Imaging Study findings, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 23 March.
Trading places: What happens when neuroscience turns into machine learning, and machine learning turns into neuroscience?
Neuroscience has become increasingly concerned with prediction, and machine learning with causal explanation, with each field adopting methods from the other. I asked eight experts to weigh in on what we stand to learn from this exchange.
Trading places: What happens when neuroscience turns into machine learning, and machine learning turns into neuroscience?
Neuroscience has become increasingly concerned with prediction, and machine learning with causal explanation, with each field adopting methods from the other. I asked eight experts to weigh in on what we stand to learn from this exchange.
Exon-skipping approach boosts levels of key Rett syndrome protein
Deleting a small region of the MECP2 gene partially restored function in neurons derived from people with Rett-associated variants.
Exon-skipping approach boosts levels of key Rett syndrome protein
Deleting a small region of the MECP2 gene partially restored function in neurons derived from people with Rett-associated variants.